News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
338,002 Results
Type
Article (16303)
Company Profile (45)
Press Release (321634)
Multimedia
Podcasts (82)
Webinars (24)
Section
Business (105046)
Career Advice (347)
Deals (18247)
Drug Delivery (76)
Drug Development (36877)
Employer Resources (53)
FDA (6607)
Job Trends (7624)
News (166074)
Policy (12803)
Tag
2027 Bio NC Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (2)
Academia (1400)
Accelerated approval (22)
Adcomms (7)
Allergies (90)
Alliances (36430)
ALS (125)
Alzheimer's disease (921)
Antibody-drug conjugate (ADC) (352)
Approvals (6973)
Artificial intelligence (512)
Autoimmune disease (207)
Automation (45)
Bankruptcy (167)
Best Places to Work (6492)
BIOSECURE Act (12)
Biosimilars (154)
Biotechnology (38)
Bladder cancer (93)
Brain cancer (45)
Breast cancer (447)
Cancer (3520)
Cardiovascular disease (278)
Career advice (313)
Career pathing (17)
CAR-T (197)
CDC (20)
Celiac Disease (2)
Cell therapy (580)
Cervical cancer (27)
Clinical research (32753)
Collaboration (1922)
Company closure (1)
Compensation (319)
Complete response letters (34)
COVID-19 (1377)
CRISPR (81)
C-suite (804)
Cystic fibrosis (73)
Data (4228)
Decentralized trials (3)
Denatured (47)
Depression (96)
Dermatology (59)
Diabetes (278)
Diagnostics (3629)
Digital health (33)
Diversity (11)
Diversity, equity & inclusion (16)
Drug discovery (249)
Drug pricing (80)
Drug shortages (16)
Duchenne muscular dystrophy (157)
Earnings (36038)
Editorial (30)
Employer branding (3)
Employer resources (54)
Events (50976)
Executive appointments (748)
FDA (8663)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1367)
Gene editing (160)
Generative AI (41)
Gene therapy (476)
GLP-1 (477)
Government (2072)
Guidances (263)
Healthcare (10190)
HIV (53)
Huntington's disease (26)
IgA nephropathy (68)
Immunology and inflammation (196)
Immuno-oncology (65)
Indications (109)
Infectious disease (1608)
Inflammatory bowel disease (118)
Inflation Reduction Act (10)
Influenza (115)
Intellectual property (190)
Interviews (34)
IPO (8321)
IRA (18)
Job creations (1325)
Job search strategy (256)
JPM (42)
Kidney cancer (10)
Labor market (42)
Layoffs (228)
Leadership (18)
Legal (2478)
Liver cancer (58)
Longevity (20)
Lung cancer (433)
Lymphoma (239)
Machine learning (46)
Management (22)
Manufacturing (790)
MASH (130)
Medical device (6610)
Medtech (6670)
Mergers & acquisitions (10736)
Metabolic disorders (764)
mRNA (148)
Multiple sclerosis (112)
NASH (10)
Neurodegenerative disease (268)
Neuropsychiatric disorders (65)
Neuroscience (1844)
Neurotech (1)
NextGen: Class of 2026 (3722)
Non-profit (2825)
Now hiring (18)
Obesity (327)
Opinion (128)
Ovarian cancer (169)
Pain (139)
Pancreatic cancer (215)
Parkinson's disease (224)
Partnered (38)
Patents (320)
Patient recruitment (343)
Peanut (24)
People (31085)
Pharmaceutical (20)
Pharmacy benefit managers (10)
Phase 1 (10420)
Phase 2 (14489)
Phase 3 (11062)
Pipeline (5767)
Policy (135)
Postmarket research (822)
Preclinical (4059)
Press Release (41)
Prostate cancer (182)
Psychedelics (23)
Radiopharmaceuticals (214)
Rare diseases (613)
Real estate (2836)
Recruiting (22)
Regulatory (11040)
Reports (19)
Research institute (1344)
Resumes & cover letters (54)
Rett syndrome (27)
RNA editing (20)
RSV (40)
Schizophrenia (118)
Series A (258)
Series B (177)
Service/supplier (3)
Sickle cell disease (58)
Special edition (12)
Spinal muscular atrophy (95)
Sponsored (27)
Startups (2646)
Stomach cancer (9)
Supply chain (88)
Tariffs (46)
The Weekly (33)
Vaccines (625)
Venture capital (88)
Weight loss (189)
Women's health (82)
Worklife (1)
Date
Today (83)
Last 7 days (276)
Last 30 days (1956)
Last 365 days (17552)
2026 (7743)
2025 (17169)
2024 (19356)
2023 (21947)
2022 (28129)
2021 (30606)
2020 (28865)
2019 (25251)
2018 (18987)
2017 (16290)
2016 (14987)
2015 (17758)
2014 (12357)
2013 (9317)
2012 (9818)
2011 (10311)
2010 (8947)
Location
Africa (320)
Alabama (66)
Alaska (7)
Arizona (128)
Arkansas (8)
Asia (22226)
Australia (3545)
California (7088)
Canada (2180)
China (841)
Colorado (335)
Connecticut (369)
Delaware (274)
Europe (54170)
Florida (1101)
Georgia (303)
Hawaii (2)
Idaho (40)
Illinois (592)
India (66)
Indiana (285)
Iowa (11)
Japan (457)
Kansas (101)
Kentucky (26)
Louisiana (24)
Maine (68)
Maryland (1013)
Massachusetts (4917)
Michigan (187)
Minnesota (339)
Mississippi (6)
Missouri (84)
Montana (17)
Nebraska (6)
Nevada (90)
New Hampshire (90)
New Jersey (2053)
New Mexico (22)
New York (1824)
North Carolina (945)
North Dakota (9)
Northern California (3508)
Ohio (223)
Oklahoma (15)
Oregon (16)
Pennsylvania (1451)
Puerto Rico (11)
Rhode Island (25)
South America (427)
South Carolina (42)
South Dakota (2)
Southern California (2840)
Tennessee (142)
Texas (1289)
United States (25677)
Utah (192)
Vermont (1)
Virginia (183)
Washington D.C. (30)
Washington State (594)
West Virginia (4)
Wisconsin (75)
Wyoming (2)
338,002 Results for "thomas h lee partners lp thl".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Agiliti to Be Taken Private by THL Partners
Agiliti Inc. announced that it has entered into a definitive merger agreement pursuant to which an affiliate of private equity firm Thomas H. Lee Partners, L.P., the company’s majority shareholder, will acquire all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates and certain management shareholders for $10.00 per share in cash, implying an enterprise value of approximately $2.5 billion.
February 26, 2024
·
8 min read
Press Releases
GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial
April 8, 2026
·
6 min read
Press Releases
Lantern Pharma Announces Successful Outcome of FDA Type C Meeting Request for HARMONIC™ Phase 2 Trial of LP-300 in Never-Smokers with NSCLC
May 19, 2026
·
14 min read
Press Releases
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
April 30, 2026
·
7 min read
Press Releases
Gan & Lee Pharmaceuticals Signs Exclusive License Agreement with JW Pharmaceutical, the Leading South Korean Pharma, to Advance the Global Commercialization of the Innovative GLP-1 Receptor Agonist Bofanglutide
April 10, 2026
·
8 min read
Press Releases
NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics
March 11, 2026
·
1 min read
Press Releases
Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress
May 26, 2026
·
5 min read
Press Releases
Guangzhou Lupeng/Newave Pharmaceutical Inc. Enrolled the First Patient in the Global Phase 3 ROCKET-CLL Trial Evaluating Rocbrutinib (LP-168) vs. Pirtobrutinib in R/R CLL/SLL
Head-to-Head Study Highlights Rocbrutinib as the World’s First Fourth-Generation Dual Covalent and Non-Covalent BTK Inhibitor Designed to Overcome Resistance Mutations
May 21, 2026
·
1 min read
Press Releases
Tango Therapeutics Appoints Sung Lee to Board of Directors
January 5, 2026
·
8 min read
Press Releases
Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors
May 13, 2026
·
3 min read
1 of 33,801
Next
